Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 287

    1.

    Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

    Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A.

    Ann Intern Med. 1998 Jul 1;129(1):18-26.PMID: 9652995 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

    Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB.

    Ann Intern Med. 1996 Dec 1;125(11):873-82.PMID: 8967667 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

    Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, Basgoz N, Klibanski A.

    J Clin Endocrinol Metab. 1996 Nov;81(11):4051-8.PMID: 8923860 [PubMed - indexed for MEDLINE]Related articles

    4.

    Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.

    Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, Basgoz N, Hirschhorn L, Tuomala R, Schoenfeld D, Daugherty C, Mazer N, Grinspoon S.

    J Clin Endocrinol Metab. 1998 Aug;83(8):2717-25.PMID: 9709937 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.

    Strawford A, Barbieri T, Van Loan M, Parks E, Catlin D, Barton N, Neese R, Christiansen M, King J, Hellerstein MK.

    JAMA. 1999 Apr 14;281(14):1282-90.PMID: 10208143 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.

    Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, Anderson E, Stanley T, Schoenfeld D, Burrows B, Hayden D, Basgoz N, Klibanski A.

    Ann Intern Med. 2000 Sep 5;133(5):348-55.PMID: 10979879 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.

    Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G.

    J Clin Endocrinol Metab. 1998 Sep;83(9):3155-62.PMID: 9745419 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.

    Waters D, Danska J, Hardy K, Koster F, Qualls C, Nickell D, Nightingale S, Gesundheit N, Watson D, Schade D.

    Ann Intern Med. 1996 Dec 1;125(11):865-72.PMID: 8967666 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.

    Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M; ACTG 313 Study Team.

    J Clin Endocrinol Metab. 2007 Feb;92(2):563-70. Epub 2006 Nov 7.PMID: 17090640 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting.

    Hengge UR, Stocks K, Wiehler H, Faulkner S, Esser S, Lorenz C, Jentzen W, Hengge D, Goos M, Dudley RE, Ringham G.

    AIDS. 2003 Mar 28;17(5):699-710.PMID: 12646793 [PubMed - indexed for MEDLINE]Related articles

    11.

    Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.

    Grinspoon S, Corcoran C, Miller K, Biller BM, Askari H, Wang E, Hubbard J, Anderson EJ, Basgoz N, Heller HM, Klibanski A.

    J Clin Endocrinol Metab. 1997 May;82(5):1332-7. Erratum in: J Clin Endocrinol Metab 1997 Oct;82(10):3360. PMID: 9141512 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.

    Grinspoon S, Corcoran C, Stanley T, Katznelson L, Klibanski A.

    J Clin Endocrinol Metab. 1998 Dec;83(12):4251-6.PMID: 9851759 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.

    Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S.

    J Clin Endocrinol Metab. 2000 Jan;85(1):35-41.PMID: 10634360 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Sustained anabolic effects of long-term androgen administration in men with AIDS wasting.

    Grinspoon S, Corcoran C, Anderson E, Hubbard J, Stanley T, Basgoz N, Klibanski A.

    Clin Infect Dis. 1999 Mar;28(3):634-6.PMID: 10194091 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.

    Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM; AIDS Clinical Trials Group Protocol A5079 Study Team.

    J Clin Endocrinol Metab. 2007 Mar;92(3):1049-57. Epub 2006 Dec 12.PMID: 17164307 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men.

    Grinspoon S, Corcoran C, Stanley T, Baaj A, Basgoz N, Klibanski A.

    J Clin Endocrinol Metab. 2000 Jan;85(1):60-5.PMID: 10634364 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.

    Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK.

    J Clin Endocrinol Metab. 2001 May;86(5):2020-6.PMID: 11344201 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women.

    Hengge UR, Stocks K, Faulkner S, Wiehler H, Lorenz C, Jentzen W, Hengge D, Ringham G.

    HIV Clin Trials. 2003 May-Jun;4(3):150-63.PMID: 12815555 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.

    Bhasin S, Storer TW, Javanbakht M, Berman N, Yarasheski KE, Phillips J, Dike M, Sinha-Hikim I, Shen R, Hays RD, Beall G.

    JAMA. 2000 Feb 9;283(6):763-70.PMID: 10683055 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy.

    Moyle GJ, Daar ES, Gertner JM, Kotler DP, Melchior JC, O'brien F, Svanberg E; Serono 9037 Study Team.

    J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):367-75.PMID: 15097153 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data